Health Press Release – Newsletter for February 24, 2011

Ingenuity Systems and Covance Collaborate to Support Next-Generation Sequencing Research

REDWOOD CITY, California, February 23, 2011 – Ingenuity(R) Systems, a leading provider of information and analytics
solutions for life science researchers, today announced a research
collaboration with Covance Genomics Laboratory (www.covance.com/cgl) for
next-generation sequencing (NGS) data analysis. Covance Genomics Laboratory,
a leading provider of genomics solutions for the drug discovery and
development industry, and Ingenuity will work together to …. Source  : Gaea News Network.

New Initiative in the Fight Against Neglected Tropical Diseases

LEIDEN, Netherlands, February 23, 2011 – Today, a new initiative, based in the Netherlands, is being launched in
the fight against neglected tropical diseases: The European Solutions
Enterprise for Neglected Diseases (euSEND). euSEND is a joint initiative of
the Academic Medical Center of the University of Amsterdam (AMC), the Royal
Tropical Institute (KIT), the Amsterdam Institute for Global … Read this article on Gaea Times at : New Initiative in the Fight Against Neglected Tropical Diseases.

New NICE Guidelines – All Children and Young People With Suspected Food Allergy Should be Offered an Allergy Test

UPPSALA, Sweden, February 23, 2011 – The first guidelines for food allergy in children and young people issued
by NICE, National Institute for health and Clinical Excellence, recommend
routine use of allergy tests in NHS primary care and community settings to
confirm suspected food allergy. These new evidence-based guidelines support
earlier diagnosis and assessment of food allergy and … Original source on Gaea Times at : New NICE Guidelines – All Children and Young People With Suspected Food Allergy Should be Offered an Allergy Test.

Oncolytics Biotech(R) Inc. Announces Completion of Enrollment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients With Metastatic Colorectal Cancer

CALGARY, Alberta, February 23, 2011 – Oncolytics Biotech Inc. ("Oncolytics") (TSX: ONC) (NASDAQ: ONCY)
announced today that enrollment has been completed in a U.K. translational
clinical trial investigating intravenous administration of REOLYSIN in
patients with metastatic colorectal cancer prior to surgical resection of
liver metastases (REO 013). The principal investigator is Professor Alan
Melcher of St. James's University Hospital …. Original article  : Oncolytics Biotech(R) Inc. Announces Completion of Enrollment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients With Metastatic Colorectal Cancer.

Leaders in Pre Formulation and Formulation to Meet This April

LONDON, February 23, 2011 – Senior leaders from across the industry will meet at Pharma
IQ's Global Pre Formulation and Formulation Summit in Amsterdam this April to
discuss latest developments and challenges in the field.

With the cost of discovering and developing a new drug
predicted to tip at approximately $900 million, the pressure … Read the original article on Gaea Times at : Leaders in Pre Formulation and Formulation to Meet This April.

Agendia Receives Fifth FDA Clearance for Industry Leading MammaPrint(R) Assay

IRVINE, California and AMSTERDAM, February 23, 2011 – Agendia, a world leader in molecular cancer diagnostics, today
announced that the company has received its fifth U.S. Food and Drug
Administration (FDA) clearance for MammaPrint(R), its widely used breast
cancer recurrence assay. The new clearance is comprised of two additional
Agilent Microarray scanners and two Agilent Bioanalyzers, expanding
laboratory capacity … Original article on : Agendia Receives Fifth FDA Clearance for Industry Leading MammaPrint(R) Assay.

Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating

HARLEYSVILLE, Pennsylvania, February 23, 2011 – Colorcon, Inc., today announced the expansion of its Nutraficient(R),
food supplement coating product line to include PVA-based, high-productivity
systems designed specifically for use on food supplements marketed within the
EU.

European Commission Directive (2010/69/EU), already adopted in the UK,
allows the use of existing additives in certain food supplement …. Original article  : Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating.

Berkshire Equine Vet Struck Off for Dishonesty and Breaching Racing Rules

LONDON, February 23, 2011 – The Disciplinary Committee of the Royal College of Veterinary Surgeons
last night [22 February 2011] directed that a veterinary surgeon from
Berkshire be removed from the Register, following his administration of a
prohibited substance to a racehorse and his subsequent attempts to conceal
his actions.

At a six-day hearing that …. Source  : Berkshire Equine Vet Struck Off for Dishonesty and Breaching Racing Rules.

OrthoAccel Technologies, Inc. Announces New Scientific Advisor

HOUSTON, February 23, 2011 – OrthoAccel Technologies, Inc. (www.acceledent.co.uk) developers of
the AcceleDent System (www.acceledent.co.uk), a medical device to
accelerate orthodontic treatment, announced this week that it has engaged Dr.
Dawei Liu (
www.public-health.uiowa.edu/faculty-staff/faculty/directory/faculty-detail.asp?emailAddress=dawei-liu@uiowa.edu)
as a scientific advisor. Dr. Liu's guidance and expertise will help advance
the Company's commitment to a research-focused strategy for developing and
introducing innovative new products.

…. Original article  : OrthoAccel Technologies, Inc. Announces New Scientific Advisor.

Largest U.S. Surrogacy Agency Appoints Director of Client Development, Europe

LOS ANGELES, February 23, 2011 – Since 1996, Growing Generations has been a company passionately dedicated
to the vision of creating life and in the process, changing the world. The
company's mission is simple-to make it safer, easier, and more enjoyable for
individuals and couples, surrogates, egg and sperm donors, and other
professionals, to grow families through assisted … Read more >>.